Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-04-13 Purchase | 2023-04-17 06:00 am | Oncternal Therapeutics Inc. | ONCT | BREITMEYER JAMES B Chief Executive Officer | 150,000 | $0.29286 | $43,930 | 763,176 (Indirect Direct) | View |
| 2022-01-27 Purchase | 2022-01-31 4:00 pm | Oncternal Therapeutics Inc. | ONCT | BREITMEYER JAMES B Chief Executive Officer | 25,000 | $1.6832 | $42,080 | 437,919 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-14 Option Award | 2024-02-15 6:00 pm | N/A 2034-02-14 | Oncternal Therapeutics Inc. | ONCT | BREITMEYER JAMES B Chief Executive Officer | 34,600 | $0 | 34,600 (Direct) | View |
| 2024-01-03 Tax Withholding | 2024-01-05 4:00 pm | N/A N/A | Oncternal Therapeutics Inc. | ONCT | BREITMEYER JAMES B Chief Executive Officer | 55,440 | $0.4961 | 655,737 (Direct) | View |
| 2023-10-02 Disposition | 2023-10-04 5:00 pm | N/A 2029-09-12 | Oncternal Therapeutics Inc. | ONCT | BREITMEYER JAMES B Chief Executive Officer | 2,601,140 | $0 | 2,591,380 (Direct) | View |
| 2023-10-02 Option Award | 2023-10-04 5:00 pm | N/A 2029-09-12 | Oncternal Therapeutics Inc. | ONCT | BREITMEYER JAMES B Chief Executive Officer | 2,601,140 | $0 | 2,591,380 (Direct) | View |
| 2023-07-03 Tax Withholding | 2023-07-05 6:59 pm | N/A N/A | Oncternal Therapeutics Inc. | ONCT | BREITMEYER JAMES B Chief Executive Officer | 51,999 | $0.36 | 711,177 (Direct) | View |
| 2023-02-21 Option Award | 2023-02-24 4:00 pm | N/A 2033-02-21 | Oncternal Therapeutics Inc. | ONCT | BREITMEYER JAMES B Chief Executive Officer | 757,196 | $0 | 757,196 (Direct) | View |
| 2023-01-03 Tax Withholding | 2023-01-05 6:00 pm | N/A N/A | Oncternal Therapeutics Inc. | ONCT | BREITMEYER JAMES B Chief Executive Officer | 29,118 | $1.02 | 613,176 (Direct) | View |
| 2022-07-28 Option Award | 2022-08-01 6:18 pm | N/A 2032-07-28 | Oncternal Therapeutics Inc. | ONCT | BREITMEYER JAMES B Chief Executive Officer | 340,625 | $0 | 778,544 (Direct) | View |
| 2022-06-21 Option Award | 2022-06-23 4:30 pm | N/A 2032-06-20 | OTONOMY INC. | OTIC | BREITMEYER JAMES B Director | 27,500 | $0 | 27,500 (Direct) | View |
| 2022-03-07 Disposition | 2022-03-09 7:16 pm | N/A 2024-03-24 | ZOGENIX INC. | ZGNX | BREITMEYER JAMES B Director | 76,625 | $0 | 0 (Direct) | View |
| 2022-03-07 Equity Swap | 2022-03-09 7:16 pm | N/A N/A | ZOGENIX INC. | ZGNX | BREITMEYER JAMES B Director | 1,250 | $0 | 0 (Direct) | View |
| 2022-01-20 Option Award | 2022-01-24 4:14 pm | N/A 2032-01-20 | Oncternal Therapeutics Inc. | ONCT | BREITMEYER JAMES B Chief Executive Officer | 802,000 | $0 | 802,000 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 7:00 pm | N/A N/A | Oncternal Therapeutics Inc. | ONCT | BREITMEYER JAMES B Chief Executive Officer | 135,350 | $0 | 413,219 (Direct) | View |
| 2021-06-22 Option Award | 2021-06-24 5:00 pm | N/A 2031-06-21 | OTONOMY INC. | OTIC | BREITMEYER JAMES B Director | 17,500 | $0 | 17,500 (Direct) | View |
| 2021-05-27 Option Award | 2021-05-28 8:03 pm | N/A 2031-05-27 | ZOGENIX INC. | ZGNX | BREITMEYER JAMES B Director | 22,000 | $0 | 22,000 (Direct) | View |
| 2021-03-18 Option Award | 2021-03-22 4:00 pm | N/A 2028-11-14 | Oncternal Therapeutics Inc. | ONCT | BREITMEYER JAMES B Chief Executive Officer | 63,295 | $0 | 105,492 (Direct) | View |
| 2021-01-27 Option Award | 2021-02-23 8:12 pm | N/A 2031-01-27 | Oncternal Therapeutics Inc. | ONCT | BREITMEYER JAMES B Chief Executive Officer | 9,000 | $0 | 9,000 (Indirect) | View |
| 2021-02-11 Option Award | 2021-02-16 6:00 pm | N/A 2031-02-11 | Oncternal Therapeutics Inc. | ONCT | BREITMEYER JAMES B Chief Executive Officer | 750,000 | $0 | 750,000 (Direct) | View |
| 2020-03-17 Option Award(A) | 2020-07-31 9:05 pm | N/A 2030-03-17 | Oncternal Therapeutics Inc. | ONCT | BREITMEYER JAMES B Chief Executive Officer | 66,890 | $0 | 66,890 (Direct) | View |
| 2020-01-07 Option Award(A) | 2020-07-31 9:05 pm | N/A 2030-01-07 | Oncternal Therapeutics Inc. | ONCT | BREITMEYER JAMES B Chief Executive Officer | 22,000 | $0 | 22,000 (Indirect) | View |
| 2020-05-29 Option Award | 2020-06-29 9:12 pm | N/A 2030-05-29 | ZOGENIX INC. | ZGNX | BREITMEYER JAMES B Director | 13,000 | $0 | 13,000 (Direct) | View |
| 2020-06-23 Option Award | 2020-06-25 5:07 pm | N/A 2030-06-22 | OTONOMY INC. | OTIC | BREITMEYER JAMES B Director | 17,500 | $0 | 17,500 (Direct) | View |
| 2020-03-17 Option Award | 2020-03-18 6:52 pm | N/A 2030-03-17 | Oncternal Therapeutics Inc. | ONCT | BREITMEYER JAMES B Chief Executive Officer | 66,890 | $0 | 66,890 (Direct) | View |
| 2020-01-07 Option Award | 2020-01-09 4:00 pm | N/A 2030-01-07 | Oncternal Therapeutics Inc. | ONCT | BREITMEYER JAMES B Chief Executive Officer | 22,000 | $0 | 22,000 (Indirect) | View |